Dror Ortho-Design, Inc.

DROR ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $2.6K $1.0K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $815.9K $1.5M $1.1M $850.7K
SG&A Expense $1.4M $1.4M $1.1M $814.7K $97.5K $87.4K $82.5K
Operating Income $-2.2M $-5.2M $-4.4M $-1.7M $-170.3K $-167.7K $-133.9K
Operating Margin -6,631.7% -16,770.7%
Interest Expense $14 $207 $279 $239
Pretax Income $-2.5M $-5.8M $-3.6M $-1.7M $-170.5K $-168.0K $-134.1K
Income Tax Expense $75
Net Income $-2.5M $-5.8M $-3.6M $-1.7M $-170.5K $-168.0K $-134.2K
Net Margin -6,639.8% -16,798.6%
EPS (Basic) $0.00 $-0.01 $-0.01 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $-0.01 $-0.01 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 977.0M 957.0M 672.5M 593.3M 875.5M 809.2M 809.2M 809.2M
Shares Outstanding (Diluted) 977.0M 957.0M 672.5M 593.3M 875.5M 809.2M 809.2M 809.2M
Dividends Per Share
← Newer Page 1 of 2 Older →